Hilary Reno, MD, PhD presents on opening day of the STD Prevention Conference on how testing for STD’s plummeted during the pandemic

Hilary Reno, MD, PhD presents on opening day of the STD Prevention Conference on how testing for STD’s plummeted during the pandemic
Public health experts discussed how nationwide trends of gonorrhea, chlamydia, and syphilis testing and diagnosis have been affected by the COVID-19 pandemic at a virtual roundtable as part of the 2020 STD Prevention Conference September 14. Reported cases of the sexually transmitted diseases/infections declined during shelter-in-place orders throughout much of the United States in March, […]

ID faculty receive funding from Foundation for Barnes-Jewish Hospital to conduct COVID-19 research

ID faculty receive funding from Foundation for Barnes-Jewish Hospital to conduct COVID-19 research
The Washington University Institute of Clinical & Translational Sciences,  with support from The Foundation for Barnes-Jewish Hospital (FBJH), has awarded funding to faculty members for COVID-19 translational research. The grants, part of the COVID-19 Research Funding Program, provide critical financial support for research that has the potential to influence COVID-19 patient care within the next […]

Jonathan Miner MD, PhD, joins the Division of Infectious Diseases

Jonathan Miner MD, PhD, joins the Division of Infectious Diseases
Jonathan Miner MD, PhD, completed his residency in internal medicine and a fellowship in rheumatology at Washington University School of Medicine. (WUSM) He completed a postdoctoral fellowship in Mike Diamond’s lab and became faculty in the Department of Medicine, Rheuematology in 2016. Dr. Miner is an extremely accomplished physician-scientist whose laboratory studies the intersection of […]

Sharmila Nair, PhD, joins the Division of Infectious Diseases

Sharmila Nair, PhD, joins the Division of Infectious Diseases
Sharmila Nair, PhD, joined the Department of Medicine in the Division of Infectious Diseases as an Instructor in July, 2020. Dr. Nair grew up in India completed her Bachelor’s degree at the Amity University, India. She was interested in infectious diseases, especially dengue at that time, and moved to England to pursue her Masters by […]

Journal of Infectious Diseases publishes supplement 2020 Inclusion, Diversity, Access and Equity in Infectious Diseases: Nurturing the Next Generation of Clinicians, Scientists and Leaders

Journal of Infectious Diseases publishes supplement 2020 Inclusion, Diversity, Access and Equity in Infectious Diseases: Nurturing the Next Generation of Clinicians, Scientists and Leaders
A new collection of articles, now available online, highlights the critical importance of nurturing a diverse next generation of infectious diseases specialists and leaders. Published as an IDSA-sponsored supplement to The Journal of Infectious Diseases, the articles build on a 2019 supplement, part of an ongoing effort to improve inclusion, diversity, access, and equity within IDSA and the […]

Independent scientists are calling on drugmakers to be more transparent about COVID-19 clinical trials and safety concerns. Mati Hlatshwayo Davis, MD, MPH joins several media outlets to discuss facts over fear.

Independent scientists are calling on drugmakers to be more transparent about COVID-19 clinical trials and safety concerns. Mati Hlatshwayo Davis, MD, MPH joins several media outlets to discuss facts over fear.
Dr. Hlatshwayo Davis, ID fellow alumna ’18 and instructor of medicine, speaks to NBC News Now about COVID-19 vaccine transparency , the rising numbers in the Midwest and indoor dining during the pandemiic. Mati Hlatshwayo Davis, MD, MPH was recently featured in several media channels speaking on COVID-19, community engagement and advocacy for marginalized communities. […]

Novel clinical trial launched to test multiple therapeutics to treat COVID-19

Novel clinical trial launched to test multiple therapeutics to treat COVID-19
The Infectious Disease Clinical Research Unit at Washington University School of Medicine has launched the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, which will be conducted by the AIDS Clinical Trials Group. The school’s Infectious Disease Clinical Research Unit is one of 25 initial sites conducting ACTIV-2, which includes both phase 2 and phase […]

Baldridge receives prestigious award as Investigator in the Pathogenesis of Infectious Diseases by the Burroughs Wellcome Fund

Baldridge receives prestigious award as Investigator in the Pathogenesis of Infectious Diseases by the Burroughs Wellcome Fund
Megan Baldridge, MD, PhD, an assistant professor of medicine at Washington University School of Medicine in St. Louis, has been named an Investigator in the Pathogenesis of Infectious Diseases by the Burroughs Wellcome Fund. Each awardee receives $500,000 over five years to support research projects that hold the potential to significantly advance understanding of how […]

Matifadza Hlatshwayo Davis, M.D., MPH, shares her opinion with Newsweek “Rushing a COVID-19 Vaccine Risks Leaving Behind the People Most at Risk”

Matifadza Hlatshwayo Davis, M.D., MPH, shares her opinion with Newsweek “Rushing a COVID-19 Vaccine Risks Leaving Behind the People Most at Risk”
Matifadza Hlatshwayo Davis, MD, MPH, ID alumae ’18, is a clinical instructor in infectious diseases at Washington University School of Medicine and the John Cochran VA Medical Center in St. Louis, as well as an infectious diseases physician and researcher.  Dr. Davis discusses how there are alarmingly few vaccine volunteers from the communities who have […]

WUSM ID Fellows, Miguel Chavez and Nathanial Nolan, launch ID Fellows Network on Twitter (#ID_fellows), an educational space for fellows by fellows

WUSM ID Fellows, Miguel Chavez and Nathanial Nolan, launch ID Fellows Network on Twitter (#ID_fellows), an educational space for fellows by fellows
Inspired by all the fantastic #MedEd content provided by #IDtwitter community, several fellows have joined resources to create the ID Fellows Network (#ID_fellows), an educational space for fellows by fellows.This is a collaborative approach to promote ID clinical reasoning for fellows.  In just under 2 months they have over 2,400 Followers. They share tweetorials, clinical […]

IDSA honors Rachel Presti, MD, PhD, among distinguished physicians, scientists with FIDSA Designation

IDSA honors Rachel Presti, MD, PhD, among distinguished physicians, scientists with FIDSA Designation
The Infectious Diseases Society of America (IDSA), the nation’s leading infectious diseases professional society, recognizes the distinguished physicians and scientists from the United States and around the world who were elected this year to be Fellows of IDSA. This year, Rachel M. Presti, MD, PhD, Associate Professor of Medicine, Infectious Diseases Division,  was honored with […]

ID-CRU launches novel clinical trial to test multiple therapeutics to treat COVID-19

ID-CRU launches novel clinical trial to test multiple therapeutics to treat COVID-19
The Infectious Disease Clinical Research Unit at Washington University School of Medicine has launched the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, which will be conducted by the AIDS Clinical Trials Group. The school’s Infectious Disease Clinical Research Unit is one of 25 initial sites conducting ACTIV-2, which includes both phase 2 and phase […]